Close

Publications

A Dose Reduction Immunobridging and Safety Study of Two Human Papillomavirus Vaccines in Tanzanian Girls (DoRIS): Enrolment and Progress to Date.
WATSON-JONES, D;
2018
(2018).
Satzke, C; Dunne, EM; Choummanivong, M; Ortika, BD; Neal, EF G; Pell, CL; Nation, ML; Fox, KK; Nguyen, CD; Gould, KA; Hinds, J; Chanthongthip, A; Xeuatvongsa, A; MULHOLLAND, EK; Sychareun, V; Russell, FM;
2018
Vaccine, (2018).37 2 10.1016/j.vaccine.2018.10.077.
LARSON, HJ;
2018
Lancet (London, England), (2018).392 10161 10.1016/s0140-6736(18)32608-4.
Wilcox, CR; Calvert, A; Metz, J; KILICH, E; MacLeod, R; Beadon, K; Heath, PT; Khalil, A; Finn, A; Snape, MD; Vandrevala, T; Nadarzynski, T; Coleman, MA; Jones, CE;
2018
The Pediatric infectious disease journal, (2018).38 6 10.1097/INF.0000000000002242.
ADETIFA, IM O; Karia, B; Mutuku, A; Bwanaali, T; Makumi, A; Wafula, J; Chome, M; Mwatsuma, P; Bauni, E; Hammitt, LL; Mataza, C; Tabu, C; Kamau, T; Williams, TN; SCOTT, JA G;
2018
Vaccine, (2018).36 52 10.1016/j.vaccine.2018.11.005.
Vaccine Safety Surveillance in Pregnancy Using Gaia Definitions for Neonatal Conditions: A Feasibility Assessment in Low- and Middle-Income Countries.
Stuurman, AL; Riera, M; Lamprianou, S; Perez-Vilar, S; Anderson, SA; MANGTANI, P; Devlieger, H; Verstraeten, T; Zuber, P; Maure, CG;
2018
DRUG SAFETY, (2018).41 11
Schrager, LK; HARRIS, RC; Vekemans, J;
2018
F1000Research, (2018).7, 10.12688/f1000research.16521.2.